Ignite Creation Date:
2024-05-06 @ 3:54 PM
Last Modification Date:
2024-10-26 @ 1:59 PM
Study NCT ID:
NCT04797780
Status:
RECRUITING
Last Update Posted:
2024-03-13
First Post:
2021-03-11
Brief Title:
Tamibarotene Plus Azacitidine in Participants With Newly Diagnosed RARA-positive Higher-Risk Myelodysplastic Syndrome
Sponsor:
Syros Pharmaceuticals
Organization:
Syros Pharmaceuticals
Organization Data
Organization:
Syros Pharmaceuticals
Class:
INDUSTRY
Study ID:
SY-1425-301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Syros Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None